Rel-Oxyphyllanene E

Details

Top
Internal ID de42f03e-76c3-4996-83d7-b779e9b08dda
Taxonomy Lipids and lipid-like molecules > Prenol lipids > Sesquiterpenoids > Eudesmane, isoeudesmane or cycloeudesmane sesquiterpenoids
IUPAC Name (2R,4aR,7S,8aR)-4a-methyl-8-methylidene-2-prop-1-en-2-yl-3,4,5,6,7,8a-hexahydro-1H-naphthalene-2,7-diol
SMILES (Canonical) CC(=C)C1(CCC2(CCC(C(=C)C2C1)O)C)O
SMILES (Isomeric) CC(=C)[C@]1(CC[C@]2(CC[C@@H](C(=C)[C@@H]2C1)O)C)O
InChI InChI=1S/C15H24O2/c1-10(2)15(17)8-7-14(4)6-5-13(16)11(3)12(14)9-15/h12-13,16-17H,1,3,5-9H2,2,4H3/t12-,13-,14+,15+/m0/s1
InChI Key HMYKTCAHZPOVHL-BYNSBNAKSA-N
Popularity 1 reference in papers

Physical and Chemical Properties

Top
Molecular Formula C15H24O2
Molecular Weight 236.35 g/mol
Exact Mass 236.177630004 g/mol
Topological Polar Surface Area (TPSA) 40.50 Ų
XlogP 2.30
Atomic LogP (AlogP) 2.81
H-Bond Acceptor 2
H-Bond Donor 2
Rotatable Bonds 1

Synonyms

Top
CHEMBL1949798

2D Structure

Top
2D Structure of Rel-Oxyphyllanene E

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9965 99.65%
Caco-2 + 0.6905 69.05%
Blood Brain Barrier + 0.6500 65.00%
Human oral bioavailability + 0.5429 54.29%
Subcellular localzation Mitochondria 0.4902 49.02%
OATP2B1 inhibitior - 0.8492 84.92%
OATP1B1 inhibitior + 0.9476 94.76%
OATP1B3 inhibitior + 0.9460 94.60%
MATE1 inhibitior - 1.0000 100.00%
OCT2 inhibitior - 0.6099 60.99%
BSEP inhibitior - 0.9023 90.23%
P-glycoprotein inhibitior - 0.9597 95.97%
P-glycoprotein substrate - 0.7935 79.35%
CYP3A4 substrate + 0.5562 55.62%
CYP2C9 substrate - 0.5811 58.11%
CYP2D6 substrate - 0.7340 73.40%
CYP3A4 inhibition - 0.6526 65.26%
CYP2C9 inhibition - 0.9101 91.01%
CYP2C19 inhibition - 0.7244 72.44%
CYP2D6 inhibition - 0.9302 93.02%
CYP1A2 inhibition - 0.7231 72.31%
CYP2C8 inhibition - 0.9062 90.62%
CYP inhibitory promiscuity - 0.8026 80.26%
UGT catelyzed + 0.7000 70.00%
Carcinogenicity (binary) - 0.8600 86.00%
Carcinogenicity (trinary) Non-required 0.5146 51.46%
Eye corrosion - 0.9880 98.80%
Eye irritation + 0.6797 67.97%
Skin irritation - 0.5250 52.50%
Skin corrosion - 0.9442 94.42%
Ames mutagenesis - 0.7900 79.00%
Human Ether-a-go-go-Related Gene inhibition - 0.5495 54.95%
Micronuclear - 0.9500 95.00%
Hepatotoxicity - 0.5143 51.43%
skin sensitisation + 0.6018 60.18%
Respiratory toxicity - 0.5333 53.33%
Reproductive toxicity + 0.9111 91.11%
Mitochondrial toxicity + 0.8000 80.00%
Nephrotoxicity + 0.6646 66.46%
Acute Oral Toxicity (c) III 0.7518 75.18%
Estrogen receptor binding - 0.7981 79.81%
Androgen receptor binding - 0.6962 69.62%
Thyroid receptor binding - 0.7178 71.78%
Glucocorticoid receptor binding + 0.5464 54.64%
Aromatase binding - 0.6025 60.25%
PPAR gamma - 0.8116 81.16%
Honey bee toxicity - 0.8617 86.17%
Biodegradation - 0.5750 57.50%
Crustacea aquatic toxicity - 0.5400 54.00%
Fish aquatic toxicity + 0.9889 98.89%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL4026 P40763 Signal transducer and activator of transcription 3 91.98% 82.69%
CHEMBL1937 Q92769 Histone deacetylase 2 91.83% 94.75%
CHEMBL253 P34972 Cannabinoid CB2 receptor 91.53% 97.25%
CHEMBL221 P23219 Cyclooxygenase-1 90.87% 90.17%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 90.16% 96.09%
CHEMBL1994 P08235 Mineralocorticoid receptor 88.84% 100.00%
CHEMBL241 Q14432 Phosphodiesterase 3A 86.10% 92.94%
CHEMBL3137262 O60341 LSD1/CoREST complex 84.41% 97.09%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 83.96% 91.11%
CHEMBL1907600 Q00535 Cyclin-dependent kinase 5/CDK5 activator 1 83.30% 93.03%
CHEMBL259 P32245 Melanocortin receptor 4 81.61% 95.38%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 81.38% 94.45%
CHEMBL1977 P11473 Vitamin D receptor 81.13% 99.43%
CHEMBL2581 P07339 Cathepsin D 80.47% 98.95%

Cross-Links

Top
PubChem 57400339
NPASS NPC245795
LOTUS LTS0015634
wikiData Q105030749